[The endocrine heart and inflammation]

Area of Science:

• Cardiology
• Immunology
• Endocrinology

Background:

• The endocrine heart produces Atrial Natriuretic Factor (ANF) and Brain Natriuretic Peptide (BNP), regulating cardiac preload and afterload.
• Emerging research highlights novel functions for ANF and BNP in modulating immune responses.
• Elevated BNP levels are observed in inflammatory conditions and post-cardiac transplant rejection.

Purpose of the Study:

• To investigate the role of natriuretic peptides (ANF and BNP) as biomarkers in cardiovascular diseases.
• To characterize the interaction between BNP and the immune response, particularly in inflammatory pathologies.
• To differentiate the roles of ANF and BNP in reflecting hemodynamic changes versus inflammatory processes.

Main Methods:

• Observational studies correlating plasma levels of ANF and BNP with specific clinical conditions.
• In vitro investigations examining the direct effects of BNP on immunological activity.
• Analysis of gene transcriptional activity of BNP in response to cytokines and inflammatory stimuli.

Main Results:

• Plasma BNP levels increase following cardiac allotransplant rejection and decrease with successful treatment.
• Several inflammatory pathologies are associated with increased BNP production due to enhanced gene transcription.
• In vitro studies confirm that elevated BNP directly modulates immune activity.
• ANF levels correlate with intravascular volume changes, while BNP reflects both volume and inflammation.

Conclusions:

• Circulating ANF and BNP levels can serve as valuable biomarkers.
• ANF changes may indicate hemodynamic deterioration, whereas BNP changes suggest a worsening inflammatory process.
• Measuring both ANF and BNP offers a comprehensive assessment of cardiovascular status, encompassing both hemodynamic and inflammatory components.